Optimisation of <i>Mycobacterium bovis</i> BCG Fermentation and Storage Survival

<i>Mycobacterium bovis</i> Bacillus Calmette-Guérin (<i>M. bovis</i> BCG) was generated over a century ago for protection against <i>Mycobacterium tuberculosis</i> (Mtb) and is one the oldest vaccines still in use. The BCG vaccine is currently produced using a pel...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Jordan Pascoe (Συγγραφέας), Charlotte L. Hendon-Dunn (Συγγραφέας), Colin P.D. Birch (Συγγραφέας), Gareth A. Williams (Συγγραφέας), Mark A. Chambers (Συγγραφέας), Joanna Bacon (Συγγραφέας)
Μορφή: Βιβλίο
Έκδοση: MDPI AG, 2020-09-01T00:00:00Z.
Θέματα:
Διαθέσιμο Online:Connect to this object online.
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a8d2b9af0d31454a88074872f6c487d8
042 |a dc 
100 1 0 |a Jordan Pascoe  |e author 
700 1 0 |a Charlotte L. Hendon-Dunn  |e author 
700 1 0 |a Colin P.D. Birch  |e author 
700 1 0 |a Gareth A. Williams  |e author 
700 1 0 |a Mark A. Chambers  |e author 
700 1 0 |a Joanna Bacon  |e author 
245 0 0 |a Optimisation of <i>Mycobacterium bovis</i> BCG Fermentation and Storage Survival 
260 |b MDPI AG,   |c 2020-09-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics12090900 
500 |a 1999-4923 
520 |a <i>Mycobacterium bovis</i> Bacillus Calmette-Guérin (<i>M. bovis</i> BCG) was generated over a century ago for protection against <i>Mycobacterium tuberculosis</i> (Mtb) and is one the oldest vaccines still in use. The BCG vaccine is currently produced using a pellicle growth method, which is a complex and lengthy process that has been challenging to standardise. Fermentation for BCG vaccine production would reduce the complexity associated with pellicle growth and increase batch to batch reproducibility. This more standardised growth lends itself to quantification of the total number of bacilli in the BCG vaccine by alternative approaches, such as flow cytometry, which can also provide information about the metabolic status of the bacterial population. The aim of the work reported here was to determine which batch fermentation conditions and storage conditions give the most favourable outcomes in terms of the yield and stability of live <i>M. bovis</i> BCG Danish bacilli. We compared different media and assessed growth over time in culture, using total viable counts, total bacterial counts, and turbidity throughout culture. We applied fluorescent viability dyes and flow cytometry to measure real-time within-culture viability. Culture samples were stored in different cryoprotectants at different temperatures to assess the effect of these combined conditions on bacterial titres. Roisin's minimal medium and Middlebrook 7H9 medium gave comparable, high titres in fermenters. Flow cytometry proved to be a useful tool for enumeration of total bacterial counts and in the assessment of within-culture cell viability and cell death. Of the cryoprotectants evaluated, 5% (<i>v/v</i>) DMSO showed the most significant positive effect on survival and reduced the negative effects of low temperature storage on <i>M. bovis</i> BCG Danish viability. In conclusion, we have shown a reproducible, more standardised approach for the production, evaluation, and storage of high titre, viable, BCG vaccine. 
546 |a EN 
690 |a BCG 
690 |a fermentation 
690 |a flow cytometry 
690 |a calcein violet 
690 |a sytox green 
690 |a cryoprotectant 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 12, Iss 9, p 900 (2020) 
787 0 |n https://www.mdpi.com/1999-4923/12/9/900 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/a8d2b9af0d31454a88074872f6c487d8  |z Connect to this object online.